Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Гриневич, В. Б.; Лазебник, Л. Б.; Kravchuk, Yu. A.; Радченко, В. Г.; Ткаченко, Е. И.; Pershko, A M; Селиверстов, П. В.; Саликова, С. П.; Жданов, К. В.; Козлов, К. В.; Makienko, Vladimir; Ivanyuk, E. S.; Egorov, Dmitry V.; Сас, Е. И.; Korzheva, M. D.; Kozlova, N. M.; Ratnikova, A. K.; Ratnikov, V. A.; Sitkin, Stanislav; Адашева, Т. В.; Туркина, С. В.; Абдулганиева, Д. И.; Ермолова, Т. В.; Кожевникова, С. А.; Тарасова, Л. В.; Myazin, R. G.; Khomeriki, N. M.; Пилат, Т. Л.; Kuzmina, Lyudmila P.; Khanferyan, R. A.; Novikova, V.P.; Polunina, A. V.; Хавкин, А.И.

doi:10.31146/1682-8658-ecg-208-12-4-68

Cited by 5 publications

(1 citation statement)

References 403 publications

(394 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Выявленные региональные колебание показателей, вероятно, связаны с многочисленными этническими, экономическими и культурными различиями между народами Европы и Азии. Ряд проведенных недавно исследований также показывает, что исход после заражения SARS-CoV-2 связан с расой, образом жизни, социально-экономическим статусом и статусом вакцинации [15,22,36,37].…”

unclassified

Some clinical and pathogenetic aspects of irritable bowel syndrome in patients who have undergone COVID-19

Nalyotov,

Shapchenko,

Guz

2024

jour

View full text Add to dashboard Cite

One of the manifestations of COVID-19 are complaints from the gastrointestinal tract, the frequency of which ranges from 3% to 80% of patients. The article presents up-to-date data on the pathogenesis of irritable bowel syndrome and features of the clinical picture of this disorder in patients who have undergone COVID-19. The influence of SARS-Cov-2 on the main pathogenetic links of irritable bowel syndrome is indicated. The problem of gastrointestinal tract damage in COVID-19 has not been fully studied and remains no less relevant for the occurrence of pathological processes in the respiratory tract.

show abstract

unclassified

Some clinical and pathogenetic aspects of irritable bowel syndrome in patients who have undergone COVID-19

Nalyotov,

Shapchenko,

Guz

2024

jour

View full text Add to dashboard Cite

show abstract

Proton pump inhibitors in pediatric practice

Shilova,

Alieva,

Bashkina

et al. 2023

Pediatr. farmakol.

View full text Add to dashboard Cite

The scientific review of the literature provides information on current clinical observations of the use of proton pump inhibitors in large randomized trials of Russian and foreign scientists, issues of their classification, pharmacokinetics, pharmacodynamics, pharmacogenetics, efficacy and safety of prescribing in pediatric practice, due to the growth of acid-dependent conditions in children and the need for further systematic research with the development of approaches to personalization of prescribing drugs for each age group.

show abstract

The effectiveness of the introduction of dietary therapeutic foods in the eradication of <i>Helicobacter pylori</i> in patients with chronic gastritis

Minushkin,

Nikityuk,

Pilat

et al. 2024

Medicinskij sovet

View full text Add to dashboard Cite

Introduction. In recent years, a high resistance of H. pylori infection to antibiotics has been recorded both worldwide and in the Russian Federation. This was the basis for introducing diets that increase the sensitivity of H. pylori to antibiotics into eradication schemes.Aim. To evaluate the effect of specialized therapeutic nutrition products LEOVIT GASTRO on the eradication of H. pylori.Materials and methods. Two study groups were formed: the main group – 22 patients and the control group – 20 patients. The groups were randomized from 42 patients suffering from chronic gastritis associated with H. pylori, by random sampling. To assess the tolerability of treatment, in particular, biochemical blood tests were studied.Results. Therapeutic nutrition provides a significant eradication effect against the background of antibiotic therapy. In 92% of patients, a complete absence of H. pylori contamination was detected, and in 8% of patients the degree of contamination was very weak, although initially it was pronounced, while in the control group, a complete absence of H. pylori contamination was detected in 80% of patients. Analysis of the use of specialized food products indicates the possibility of their use in diseases of the gastrointestinal tract associated with H. pylori, as they promote epithelization, healing of the mucosa, reduction and elimination of inflammation, pain, and discomfort in the gastrointestinal tract.Conclusion. Therapeutic dietary nutrition LEOVIT GASTRO is one of the important factors positively influencing the success rate of eradication treatment.

show abstract

Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines

Cited by 5 publications

References 403 publications

Some clinical and pathogenetic aspects of irritable bowel syndrome in patients who have undergone COVID-19

Some clinical and pathogenetic aspects of irritable bowel syndrome in patients who have undergone COVID-19

Proton pump inhibitors in pediatric practice

The effectiveness of the introduction of dietary therapeutic foods in the eradication of <i>Helicobacter pylori</i> in patients with chronic gastritis

Contact Info

Product

Resources

About